429 related articles for article (PubMed ID: 18005144)
1. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Martin V; Cady R; Mauskop A; Seidman LS; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144
[TBL] [Abstract][Full Text] [Related]
2. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE
Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
Cady R; Martin V; Mauskop A; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2006 Jun; 46(6):914-24. PubMed ID: 16732837
[TBL] [Abstract][Full Text] [Related]
4. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Mannix LK; Loder E; Nett R; Mueller L; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
[TBL] [Abstract][Full Text] [Related]
5. Early treatment of migraine with rizatriptan: a placebo-controlled study.
Mathew NT; Kailasam J; Meadors L
Headache; 2004; 44(7):669-73. PubMed ID: 15209688
[TBL] [Abstract][Full Text] [Related]
6. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
7. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.
Ho TW; Rodgers A; Bigal ME
Headache; 2009 Mar; 49(3):395-403. PubMed ID: 19222588
[TBL] [Abstract][Full Text] [Related]
8. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
9. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
10. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
11. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
Freitag F; Taylor FR; Hamid MA; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
[TBL] [Abstract][Full Text] [Related]
14. Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.
Ho TW; Fan X; Rodgers A; Lines CR; Winner P; Shapiro RE
Cephalalgia; 2009 Jul; 29(7):711-8. PubMed ID: 19210513
[TBL] [Abstract][Full Text] [Related]
15. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
[TBL] [Abstract][Full Text] [Related]
16. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
17. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
Mateos V; Roig C; López Rodríguez I; López-Gil A
Neurologia; 2002 Dec; 17(10):621-7. PubMed ID: 12487957
[TBL] [Abstract][Full Text] [Related]
18. Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies.
Cady R; Martin V; Mauskop A; Rodgers A; Hustad C; Ramsey K; Skobieranda F
Cephalalgia; 2007 Sep; 27(9):1055-60. PubMed ID: 17681023
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
Cutler NR; Jhee SS; Majumdar AK; McLaughlin D; Brucker MJ; Carides AD; Kramer MS; Matzura-Wolfe D; Reines SA; Goldberg MR
Headache; 1999 Apr; 39(4):264-9. PubMed ID: 15613223
[TBL] [Abstract][Full Text] [Related]
20. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
